Expression of S100a, Vimentin, NSE, and Melan A/MART-1 in Seven Canine Melanoma Cell Lines and Twenty-nine Retrospective Cases of Canine Melanoma

Veterinary Pathology

Volumn 38, Issue 4, 2001, Pages 427-435

  Koenig, A ^a   Wojcieszyn, J ^b   Weeks, B R ^a   Modiano, J F ^c,d  

^a TEXAS A AND M UNIVERSITY   (United States)

^b IHC Services   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Dogs; Immunohistochemistry; Lineage markers; Melanoma

Indexed keywords

ENOLASE; MART1 ANTIGEN; PROTEIN S 100; S100A1 PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN; VIMENTIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ANIMALS; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL LINEAGE; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; RETROSPECTIVE STUDIES; S100 PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 0035404073     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.38-4-427     Document Type: Article

References (39)

1. Argenyi ZB, Cain C, Bromley C, Nguyen AV, Abraham AA, Kerschmann R, LeBoit PE: S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 16:233-240, 1994
2. Aronsohn MG, Carpenter JL: Distal extremity melanocytic nevi and malignant melanomas in dogs. J Am Anim Hosp Assoc 26:605-612, 1990
3. Ben-Izhak O, Stark R, Levy R, Bergman R, Lichtig C: Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am J Dermatopathol 16:241-246, 1994
4. Bergman R, Azzam H, Sprecher E, Manov L, Munichor M, Friedman-Birnbaum R, Ben-Itzhak O: A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas. J Am Acad Dermatol 42:496-500, 2000
5. Blessing K, Sanders DS, Grant JJ: Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 32:139-146, 1998
6. Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA: Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 22:976-982, 1998
7. Busam KJ, Jungbluth AA: Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 6:12-18, 1999
8. Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, Old LJ: Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 93:5915-5919, 1996
9. Curry BJ, Myers K, Hersey P: MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases. J Clin Oncol 17:2562-2571, 1999
10. de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN: Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223-3229, 1997
11. Dhillon AP, Rode J, Leathern A: Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology 6:81-92, 1982
12. Dow SW, Elmslie RE, Willson AP, Roche L, Gorman C, Potter TA: In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406-2414, 1998
13. Hofbauer GF, Kamarashev J, Geertsen R, Boni R, Dummer R: Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res 8:337-343, 1998
14. Isobe T, Takahashi K, Okuyama T: S100a0 (alpha alpha) protein is present in neurons of the central and peripheral nervous system. J Neurochem 43:1494-1496, 1984
15. Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ, Chen YT: A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 22:595-602, 1998
16. Kageshita T, Kawakami Y, Hirai S, Ono T: Differential expression of MART-1 in primary and metastatic melanoma lesions. J Immunother 20:460-465, 1997
17. Kaufmann O, Koch S, Burghardt J, Audring H, Dietel M: Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 11: 740-746, 1998
18. Korabiowska M, Mirecka J, Brinck U, Szuta M, Stypulkowska J, Wiese G, Bartkowski S, Schauer A: Immunohistochemical demonstration of S100 protein in malignant melanomas of the facial skin and oral cavity. J Ninon Univ Sch Dent 36:117-121, 1994
19. Leader M, Collins M, Patel J, Henry K: Vimentin: an evaluation of its role as a tumour marker. Histopathology 11:63-72, 1987
20. Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray PH, Herlyn M, Kawakami Y, Rosenberg SA: Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother 19:192-205, 1996
21. Marino DJ, Matthiesen DT, Stefanacci JD, Moroff SD: Evaluation of dogs with digit masses: 117 cases (1981-1991). J Am Vet Med Assoc 207:726-728, 1995
22. Mehregan DR, Hamzavi I: Staining of melanocytic neoplasms by melanoma antigen recognized by T cells. Am J Dermatopathol 22:247-250, 2000
23. Modiano JF, Ritt MG, Wojcieszyn J: The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy. J Vet Intern Med 13:163-174, 1999
24. Moulton JE, ed.: Tumors in domestic animals, 3rd ed., pp. 62-70. University of California Press, Berkeley, CA, 1990
25. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 59:5464-5470, 1999
26. Orchard GE: Comparison of immunohistochemical labeling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 32:475-481, 2000
27. Palmer AA, Hall BE, Lew M: A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections. Pathology 17: 335-339, 1985
28. Pernick NL, DaSilva M, Gangi MD, Crissman J, Adsay V: "Histiocytic markers" in melanoma. Mod Pathol 12: 1072-1077, 1999
29. Rabanal RH, Fondevila DM, Montane V, Domingo M, Ferrer L: Immunocytochemical diagnosis of skin tumours of the dog with special reference to undifferentiated types. Res Vet Sci 47:129-133, 1989
30. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A, Kottler SJ: Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol 37:597-608, 2000
31. Ritt MG, Mayor J, Wojcieszyn J, Smith R, Barton CL, Modiano JF: Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition. Cancer Lett 158:73-84, 2000
32. Ritt MG, Wojcieszyn J, Modiano JF: Functional loss of p21/Waf-1 in a case of benign canine multicentric melanoma. Vet Pathol 35:94-101, 1998
33. Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S: Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88: 10657-10661, 1991
34. Sandusky GE Jr, Carlton WW, Wightman KA: Immunohistochemical staining for S100 protein in the diagnosis of canine amelanotic melanoma. Vet Pathol 22: 577-581, 1985
35. Sandusky GE, Carlton WW, Wightman KA: Diagnostic immunohistochemistry of canine round cell tumors. Vet Pathol 24:495-499, 1987
36. Shoup SA, Johnston WW, Siegler HF, Tello JW, Schlom J, Bigner DD, Bigner SH: A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma. Acta Cytol 34:385-392, 1990
37. Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T: Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol 45:385-396, 1984
38. Theon AP, Rodriguez C, Madewell BR: Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. J Am Vet Med Assoc 210:778-784, 1997
39. Wolfe LG, Oliver JL, Smith BB, Toivio-Kinnucan MA, Powers RD, Brawner WR, Henderson RA, Hankes GH: Biologic characterization of canine melanoma cell lines. Am J Vet Res 48:1642-1648, 1987